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Recent advances in the treatment of liver disease and the increased
prevalence of infectious hepatitis have stimulated interest in tests of
liver function. These have proved useful both in diagnosis and in fol-
lowing the course of liver disease. Their value, however, has been
questioned by some and overrated by others. In approaching this prob-
lem it is well to recognize at the outset that liver function tests are not
a substitute for a careful history and physical examination, that, at best,
they are confirmatory diagnostic aids, and that their interpretation
demands an understanding of their physiologic basis and recognition
of their limitations.
The term "liver function test" is somewhat misleading and, unless
its implications are fully understood, may be the basis for misunder-
standing and misinterpretation. In the first place, few of the tests em-
ployed actually measure normal physiologic functions of the liver.
Thus, while changes in the level of serum albumin and bilirubin or in
the excretion of galactose may indicate disturbances in normal functions,
the excretion of a foreign dye, such as bromsulphalein, cannot be re-
garded as a measure of any of the normal functions of the liver, even
though it may reflect abnormalities in them indirectly. Secondly, some
of the tests measure changes, which, while they may disclose the
presence of pathological processes in the liver, do not necessarily imply
any abnormality in its functions. The changes in the serum globulin
pattern, which occur so frequently in a variety of liver diseases, and
which may be crudely measured by such tests as the cephalin-cholesterol
flocculation and the thymol turbidity, are examples. Lastly, many of
the abnormalities resulting from impairment of function or from patho-
logical changes in the liver may also occur in other diseases not affecting
that organ, as, for example, the increase in serum alkaline phosphatase
which accompanies certain bone diseases. It is not surprising, then, to
learn that abnormal function tests do not necessarily imply any impair-
ment of function or the presence of any structural derangement of the
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liver. These are often erroneously called "false-positive" tests, implying
that the tests have given the wrong result, rather than that they have
been interpreted incorrectly. It must be emphasized, therefore, that
function tests have their limitations, and that it is quite impossible to
interpret them without an understanding of what they measure.
Several features of the liver make it a peculiarly difficult organ to
study functionally. Among these may be mentioned: one, the multi-
plicity of its functions, not all of which are equally or simultaneously
affected in disease; two, its tremendous reserve and regenerative power,
which permit extensive damage or removal of tissue before any of its
functions are disturbed; and, three, the intimate anatomical relationships
of its glandular, excretory, and vascular components, which make for
complex functional disturbances, even when the initial injury is con-
fined to one component. It is not difficult to understand, then, why early
attempts to find asingle comprehensive test of liver function were bound
to fail. The recent trend has been toward the use of a battery of tests,41
varying in sensitivity and measuring a variety of functions, usually per-
formed simultaneously, and often serially. While this approach has
added very materially to our understanding of liver disease, it has also
led to considerable confusion. Unfortunately, as the number and sensi-
tivity of the tests increase, they become increasingly difficult to interpret.
In general, function tests are called upon to answer one of three
questions: (1) Is liver disease present? (2) What is the nature of the
disease? (3) What course is established liver disease taking?
Usually the first question, regarding the presence of liver disease,
is raised when jaundice is absent and when hepatomegaly or spleno-
megaly is found, when there is a history of exposure to known or sus-
pected hepatotoxins, or when the symptoms suggest the onset of
infectious hepatitis. As a rule this question can be answered satisfactorily
by function tests.
The second question, regarding the nature of the disease, can rarely
be answered by function tests when jaundice is absent, since none of
the tests now available can distinguish the many known types of
parenchymal damage. Here, the diagnosis must rest on other clinical
and laboratory data. In the presence of jaundice, on the other hand, the
tests may be very helpful. As a rule, however, they are confirmatory
here rather than diagnostic. The distinction between hemolytic and
hepatic jaundice can be made with reasonable accuracy. The differen-
tiation of the jaundice due to parenchymal damage and that due to
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obstruction of the biliary tree, however, is a much more difficult prob-
lem. Here the results of function tests are much less reliable, although
still of some value. It is doubtful that any test can ever be devised to
differentiate all cases of parenchymatous from obstructive jaundice,
since purely obstructive lesions are sooner or later complicated by
parenchymal damage, and since the intimate anatomic relationship
between the parenchymal cells and the terminal biliary tree makes
selective damage to the former almost impossible. The tests are of no
value whatever in localizing obstructive lesions, and only occasionally
are they of some value in determining the nature of the obstruction.
Again, diagnosis depends on clinical observation and on other diag-
nostic measures.
The third question, regarding the progress of evident liver disease,
while it can be partially answered by clinical observation, is particularly
well covered by serial function tests, especially in the absence of jaundice
and other clinical signs of hepatic failure. They are of great value in
assessing the severity of hepatic damage and the effects of treatment,
and in determining when the liver has fully recovered from an injury.
While it is generally agreed that several function tests are required
for the adequate study of liver disease, there is no uniformity of opinion
about which of the tests serve this purpose best. Those discussed below
have been in use for several years at the Yale University School of
Medicine. With the exception of the serum lipids and proteins, the tests
have been performed simultaneously and usually serially. Those chosen
appear toprovide about as much useful information as can be reasonably
expected from this method of study. Moreover, the required blood and
excreta collections are relatively simple to carry out on the wards or in
the out-patient clinic, and the technical methods employed in analyzing
them are reliable and can be carried out in any well-equipped clinical
laboratory. No doubt there are other tests equally good, but we have
not used them, either because they are technically difficult or too time-
consuming, or because they do not appear to add any information to
that obtainable with the tests now in use.
Serum bilirubin
The level of the serum bilirubin is dependent on two factors: the
rate of bilirubin production from hemoglobin in the reticulo-endothelial
system and the rate of bilirubin excretion through the biliary tract. A
rise in serum bilirubin may, therefore, be due to: (1) excessive hemol-
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ysis resulting in increased bilirubin production, (2) failure of the liver
to remove bilirubin from the serum, or (3) regurgitation of bilirubin
from an obstructed biliary tree. In most cases of jaundice several of
these factors appear to be operative. Thus, in hemolytic jaundice ex-
cessive hemolysis is usually accompanied by impairment of bilirubin
excretion,28 and in the jaundice due to parenchymal damage bilirubin
is not only retained, due to poor excretion, but is also probably regurgi-
tated into the serum through injured canaliculi. The hyperbilirubinemia
of obstructive jaundice is still not fully understood. While most investi-
gators believe that bilirubin is regurgitated into the blood through
ruptured canaliculi28 or by diffusion through damaged terminal bile
ducts,16 the possibility has not been excluded that the parenchymal cells
fail to remove bilirubin from blood in the presence of biliary
obstruction."2,46
The qualitative van den Bergh reaction deserves comment. Since
the original observation that some jaundiced sera give an immediate
color reaction with Ehrlich's reagent and that others give a delayed re-
action, or require the presence of alcohol, there has been considerable
debate over the question of whether there are two forms of bilirubin,
and whether the type of reaction has any physiologic or diagnostic
significance. There is good reason to believe now that the two types of
reaction do not indicate chemically distinct forms of bilirubin. It is
commonly held that bilirubin, as it is formed, is bound to protein and
gives a delayed or indirect reaction, and that in traversing the cells of
the liver the bilirubin loses its protein-linkage and gives a prompt,
direct reaction.37 This view is open to serious question, since it can be
demonstrated that both "types" of bilirubin are bound to protein.31
The possibility that there are two types of protein-linkage, however,
has not been excluded,7 but recent evidence suggests that the type of
van den Bergh reaction obtained may depend not on the nature of the
bilirubin, but rather on the presence in serum of other substances which
catalyze the diazo reaction.13
The concept that the prompt, direct-reacting bilirubin has trav-
ersed the liver cells and has been regurgitated is an assumption that
still awaits proof. In any event, the qualitative van den Bergh reaction
has proved to be of no value in differentiating obstructive from
hepatocellular jaundice. Moreover, by sensitive quantitative methods it
has been possible to demonstrate both "types" of bilirubin not only in
the sera of both obstructive and hepatocellular jaundice, but also in the
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sera of normal individuals.45
Recently Watson has reported that an analysis of the van den Bergh
reaction colorimetrically confirms the presence in serum of two types
of bilirubin, and that the direct, or prompt-reacting fraction represents
regurgitated bilirubin, measured most accurately by the one-minute
reading.37 Studies in this laboratory17 have failed to confirm these find-
ings. Furthermore, in our experience the one-minute bilirubin deter-
mination has been of as little value in the differential diagnosis of
jaundice as the original qualitative van den Bergh test.
The quantitative determination of the total serum bilirubin, on the
other hand, has proved to be of great value, especially in detecting sub-
clinical jaundice and in demonstrating fluctuations in the intensity of
jaundice not apparent to the eye. The recognition of subclinical jaundice
is often of importance both in establishing a diagnosis of liver disease
and in following its course. It is important, however, to bear in mind
that an increase in serum bilirubin does not necessarily imply the
presence of liver disease. Such increases occur frequently in congestive
heart failure, pneumonia, anemia, and in a number of other diseases
unrelated to the liver.
The trend of serial serum bilirubin determinations is often of value
in following the course of liver disease. For example, in infectious
hepatitis a progressive decline usually indicates satisfactory convales-
cence and a good prognosis, while a rise following exercise indicates
continued activity and may be the first sign of a clinical relapse. The
fluctuations in serum bilirubin are also occasionally of value in the
differential diagnosis of jaundice. In carcinoma of the head of the
pancreas, for example, there is usually a slowly progressive rise in serum
bilirubin with only minor fluctuations. In biliary obstruction due to
common duct stone, on the other hand, fluctuations are more marked
and occur more rapidly.
Urine bilirubin
The renal excretion of bilirubin is thought to depend on a rise
in the prompt-reacting bilirubin level of the serum above a critical
thresholdvalue.37 Whilebilirubinuriadoes occurwith an increased direct
serum bilirubin, there is reason to question the assumption that the
two are necessarily related. For example, bilirubinuria often clears up
in convalescent infectious hepatitis and in subsiding obstructive jaundice,
while the prompt-reacting fraction of serum bilirubin is still above the
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so-called threshold level, and significant increases in prompt-reacting
serum bilirubin may occur in hemolytic jaundice without bilirubin-
uria."7 It may well be that the urinary excretion of bilirubin is dependent
on the renal effects of other substances which accumulate in the blood
of some jaundiced patients.
There are a number of simple tests for detecting the presence of
bilirubin in urine. Since bilirubinuria may occur with relatively slight
increases in serum bilirubin, the tests are often of value in recognizing
jaundice early, as in infectious hepatitis or in recent biliary obstruction,
and in following the course of jaundice, especially when it is fading.
While the presence of bilirubin in urine differentiates hepatic from
hemolytic jaundice, it cannot be used to distinguish obstructive from
parenchymatous jaundice.
Urine urobilinogen
The bilirubin excreted into the intestinal tract is converted to uro-
bilinogen by bacterial action, and is returned to the liver by way of the
portal blood. Normally, the liver removes most of this urobilinogen
and only a small fraction is excreted in the urine. Urine urobilinogen
is increased when the liver fails to clear the blood of urobilinogen. This
may occur when there is liver damage, as in hepatitis or cirrhosis, or
when the normal capacity of the liver to remove urobilinogen is ex-
ceeded by its production, as in hemolytic jaundice. Rich28 does not
believe that the increased bilirubin and urobilinogen production in
hemolytic jaundice can exceed the excretory capacity of the normal liver,
and he assumes, therefore, that liver damage, probably due to anemia,
must be present to account for the increase in urine urobilinogen.
The excretion of urobilinogen is a sensitive index of hepatic func-
tion, but normal values may be misleading unless quantitative deter-
minations are carried out serially, preferably on 24-hour collections,
and unless the state of the feces is known. Urobilinogen excretion
fluctuates over a wide range throughout the day, and from day to day,
both in normal persons and in subjects with liver disease. Moreover,
when bilirubin fails to reach the intestinal tract, due either to biliary
obstruction or to failure of the liver to excrete bile, no urobilinogen
is produced and urobilinogenuria cannot occur, even if considerable
parenchymal damage is present. This is well illustrated in infectious
hepatitis. Early in the disease there is an increased excretion of
urobilinogen. Later, as the injury increases and bile excretion is sup-
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pressed, the stools become clay colored and urobilinogen disappears
from the urine. During convalescence, as bile excretion is resumed, the
stools return to their normal color, and urobilinogen reappears in the
urine. Finally, the urobilinogen level falls to normal when complete
recovery has occurred.
Simple quantitative tests for urobilinogen are useful in establishing
the presence of liver damage and in following its progress, especially
in the absence of jaundice and when more elaborate tests are not
available. When jaundice is present tests may occasionally be of value
in differentiating hemolytic from hepatic jaundice and in estimating the
degree of biliary obstruction or suppression present. In interpreting
these tests, however, it must be recognized that increased urobilinogen
excretion may occur in a number of diseases in which the liver is not
primarily affected, such as in severe streptococcal and pneumococcal
infections, and in malaria.
Fecal urobilinogen
The urobilinogen that escapes reabsorption in the intestine is oxi-
dized to urobilin and stercobilin which impart a brown color to the
feces. When bilirubin fails to reach the intestine or is decreased in
amount, due either to biliary obstruction or to failure of the liver to
excrete it, the fecal urobilinogen falls and the feces become clay colored.
Quantitative determination in these cases, however, usually reveals the
presence of small but significant amounts of urobilinogen, indicating
that biliary obstruction is rarely complete. When fecal urobilinogen
is totally absent obstruction is complete and is usually due to
malignancy.38
The quantitative determination of fecal urobilinogen is a time-
consuming procedure and is rarely more informative than is a simple
qualitative test and inspection of the stools, except in excluding ob-
struction due to malignancy. In hemolytic jaundice the fecal urobilino-
gen is greatly increased, but quantitative determination is seldom worth-
while, since the diagnosis can be established much more easily by
npler methods. Although simultaneous fecal and urinary urobilinogen
stadies are of value in differentiating hemolytic from hepatic jaundice,
they frequently fail to differentiate obstructive from parenchymal
jaundice. This is especially true in those cases of hepatitis and cirrhosis
in which clay-colored stools and absent urobilinogenuria suggest biliary
obstruction.
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Bromsulphalein excretion
It is generally assumed that bromsulphalein is removed from blood
almost exclusively by the liver.3 Recent experiments, however, indicate
that as much as one-quarter of the injected dye may be removed in the
absence of the liver, gastro-intestinal tract, and kidneys.6 Moreover, the
dye disappears from the blood more rapidily than it is excreted in the
bile,44 and blockade of the reticulo-endothelial system results in dye
18,24 retention, suggesting that the reticulo-endothelium plays an in-
portant role in bromsulphalein excretion. Nevertheless, the rate at
which this dye is cleared from blood has proved to be a sensitive index
of hepatic parenchymal function.
In the absence of jaundice the degree of dye retention is usually
proportional to the extent of parenchymal damage present. Since the
dye is excreted via the biliary tree, retention will also occur with biliary
obstruction. Moreover, an increase in serum bilirubin may in itself pro-
duce dye retention.9 Therefore, the test is difficult to interpret in the
face of jaundice. In general, dye retention parallels the height of the
serum bilirubin in uncomplicated biliary obstruction, and is dispropor-
tionately higher when parenchymal damage is present. However, the
variations in both dye and bilirubin retention are so great that the ratio
between the two cannot be relied upon as an index of parenchymal
function in the presence of jaundice.
The bromsulphalein test has its greatest value in establishing the
presence of liver disease, and in following its course, when jaundice
is absent. As with the other tests, it is of no aid in determining the
nature of the lesion. Moreover, it has the disadvantage of being suffi-
ciently sensitive to detect minor degrees of impaired hepatic function
incidental to other diseases, such as pneumonia, anemia, and congestive
heart failure, so that these may be mistaken for primary liver disease.
Alkaline phosphatase
The serum alkaline phosphatase level is frequently elevated in liver
disease,especially in thepresenceofjaundice.Themechanismresponsible
for this increase is not fully understood. The enzyme occurs in a great
many tissues, including the liver, the bones, and the intestinal mucosa,
and is normally excreted in the bile. According to a commonly held
view the increase in serum phosphatase is a retention phenomenon, the
result of decreased hepatic excretion, due either to parenchymal damage
or to biliary obstruction.30 36 While this mechanism may account for
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the rise in serum phosphatase in extrahepatic biliary obstruction, it can
hardly be the basis for the rise which occurs in biliary fistula, nor can
it account for the relatively normal phosphatase values reported in con-
genital atresia of the bile ducts.4' Drill's work on experimental
biliary fistula suggests that retention ofphosphatase in blood may be due
notonly to a failureofbiliaryexcretion, but also to anover-production of
the enzyme by the liver which exceeds the excretory capacity of that
organ."0 Thannhauser's experiments suggest still another possible ex-
planation-that the apparent elevation of the serum phosphatase level
may not be due to an actual increase in concentration, but rather to an
increase in enzyme activity resulting from other chemical alterations
in the blood.34 Unfortunately not all workers have been able to confirm
these interesting observations.8
The alkaline phosphatase level is of relatively little significance in
the diagnosis of liver disease unaccompanied by jaundice. It is of very
real value, however, in the differential diagnosis of jaundice. The level
is usually normal in hemolytic icterus, slightly elevated in hepatocellu-
lar, and greatly elevated in obstructive jaundice. Occasionally the serum
phosphatase level rises significantly in the absence of jaundice. This is
said to occur especially in some cases of cirrhosis and in metastatic
carcinoma of the liver.11
There is a small group of cases with chronic jaundice, due primarily
to hepatocellular disease, in which the serum alkaline phosphatase is
often as greatly increased as in extrahepatic biliary obstruction. This
group includes what Watson calls "cholangiolitic hepatitis and
cirrhosis,"40 some forms of arsenical hepatitis,1 14 many cases of biliary
cirrhosis, and an occasional case of Laennec's cirrhosis. It is usually
assumed that the jaundice in these cases is due to intrahepatic biliary
obstruction or injury to the terminal branches of the biliary tree re-
sulting in regurgitation of bile into the blood. The evidence for this
assumption is by no means convincing, but whatever the mechanism,
it is an unfortunate fact that none of the tests of hepatic function can
be relied upon to distinguish this type of jaundice from that of extra-
hepatic biliary obstruction. The diagnosis in this group usually depends
almost entirely on the history and physical findings, and often cannot
be established with certainty until the liver and biliary tree have been
explored surgically.
From a practical point of view, values above 12 Bodansky units
usually indicate obstructive, and those between 5 and 10 units, hepato-
cellular jaundice. Except in the group just mentioned, there have been
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surprisingly few deviations from this rule of thumb in our series.
In the few instances in which the phosphatase has failed to rise to the
expected level in obstructive jaundice, there has usually, although not
always, been evidence to suggest that the obstruction was relieved and
that the jaundice was fading.
It is important to study the serum phosphatase serially during the
development of jaundice, since initial values may be misleading. Quite
often the alkaline phosphatase is only slightly elevated shortly after
the onset of obstruction, but as the jaundice deepens the usual sharp
increase can be demonstrated. Early in infectious hepatitis, on the
other hand, values as high as 10 and 12 units may be found, but they
do not increase as the jaundice deepens, and they usually fall.
The serum alkaline phosphatase may also rise in a variety of bone
diseases, such as Paget's disease and hyperparathyroidism, so that these
must be kept in mind, especially when the elevation is unaccompanied
by other signs of liver damage.
Serum proteins
The liver plays an important r6le in both the synthesis and storage
of proteins, which is reflected in the qualitative and quantitative com-
position of the serum proteins. In hepatocellular disease there is a
tendency for the albumin fraction to fall and the globulin fraction to
rise. While the decrease in serum albumin is clearly correlated with
hepatocellular injury, the significance of the rise in globulin is not yet
fully understood. There is evidence to indicate that the globulins are
largely extra-hepatic in origin, some arising in the lymphocytes, others
in the reticulo-endothelial system. The liver may, therefore, play a role
in globulin synthesis through its reticulo-endothelial component, the
Kupffer-cell system.43 Recent studies on the behavior of the globulins
in infectious hepatitis, suggest that globulin changes may be related
to inflammatory5 and regenerative20 processes in the liver rather than to
degenerative changes in the parenchymal cells.
In moderately severe liver injury the total serum protein falls,
almost exclusively at the expense of the albumin fraction. With less
severe injury the total proteins may remain at a normal level, despite
a decrease in albumin, because of an increase in the globulin fraction.
Finally, in some forms of chronic hepatitis'5 the increase in globulin
may be so great that the total serum protein level is raised above normal.
An analysis of the serum protein and its constituents is of the
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greatest importance in studying the state of the liver. It is of value in
the diagnosis of latent liver disease, in estimating the severity of hepato-
cellular damage, in determining the prognosis, in following the course
of established hepatic disease, and in the differential diagnosis of
jaundice.
Although changes in serum protein may occur very rapidly in
severe, acute liver injury, they usually appear later than many other
abnormalities of hepatic function. Therefore, they are of little value in
the diagnosis of early or acute liver disease, but are of the greatest im-
portance in chronic liver disease, even when the degree of damage
is not severe.
A marked fall in serum albumin usually indicates severe hepato-
cellular injury, especially when it occurs early in acute liver disease.
In infectious hepatitis, forexample, itmaybe anearly signofprogression
to acute or subacute necrosis of the liver. A rising serum albumin, on
the other hand, is a most reliable sign of improving liver function and
usually portends a favorable outcome. The serum albumin level is an
especially valuable guide in the management of chronic obstructive
jaundice complicated by hepatocellular damage, a condition in which
most tests of liver function are usually of little value.
In the differential diagnosis of jaundice, the finding of a decreased
serum albumin, or of an increased globulin, favors an hepatocellular
etiology. In general, the serum proteins are little changed in obstructive
jaundice, except when this has been present for a relatively long time,
and has been complicated by secondary parenchymal damage. Unfor-
tunately, the serum proteins are often misleading in that difficult group,
already mentioned, of "cholangiolitic" hepatitis and biliary cirrhosis, in
which the clinical and laboratory findings suggest extrahepatic obstruc-
tive jaundice. While the primary fault in these cases lies in a parenchy-
mal lesion, the serum proteins are often normal.
The serum proteins often return to normal long before many other
abnormalities of hepatic function, so that the former cannot be relied
upon to determine when complete recovery from injury has occurred,
as, for example, in infectious hepatitis. Moreover, many cases of frank
liver disease never develop gross changes in serum albumin or globulin.
Finally, caution must be used in interpreting serum protein values.
First, fractionation of the serum proteins is not a simple technique and
is subject to technical errors. Secondly, the composition of the serum
proteins is altered in a great many other diseases, and, lastly, it is in-
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fluenced by the dietary intake, an especially important factor in chronic
liver disease.
Cephalin-cholesterol flocculation and thymol turbidity tests
The serum globulins can be fractionated by salting-out methods or
by electrophoresis. In liver disease, and in a wide variety of acute and
chronic infections, parasitic infestations, and tumors, there is often a
selective increase in the individual fractions, with or without an increase
in the total globulins. Since the usual globulin fractionation methods
are too difficult and time-consuming for routine clinical use, a number
of relatively simple, although admittedly crude, tests have been devised
to measure these changes. Among these are the cephalin-cholesterol
flocculation and the thymol turbidity tests, which have proved to be
of some value in the diagnosis of liver disease. It is self-evident that
both must be interpreted with caution, since they may be positive in
any disease which alters the serum globulin pattern. This is especially
true of the cephalin-cholesterol flocculation test.
Although the results of the two tests are in agreement in many types
of liver disease,42 there are often striking discrepancies, based, no doubt,
on differences in the mechanism of the two reactions.
The cephalin-cholesterol flocculation test appears to depend pri-
marily on an increase in gamma globulin, but is also influenced, to
some extent, by a reduction or qualitative change in serum albumin.23
The thymol turbidity reaction is less well understood. According to
Cohen and Thompson' it can be correlated with the serum beta globulin
level. Kunkel,19 on the other hand, believes that the apparent changes
in beta globulin demonstrated electrophoretically depend mainly on the
serum lipid level, and are not due to alterations in the serum protein
pattern. He and others22' 27 have found that elevated thymol turbidity
values in liver disease are usually closely related to increases in gamma
globulin, and thatthe serum lipidsplay an important role in the reaction.
Both tests are of value in the diagnosis of liver disease, and are
thought to indicate hepatocellular injury. The cephalin flocculation
test is usually positive in cirrhosis and hepatitis, and is frequently posi-
tive in other diffuse hepatic lesions. The thymol turbidity test, on the
other hand, is usually positive in hepatitis, but is often negative or only
weakly positive in cirrhosis. Watson39 finds that the thymol turbidity
test is much more frequently positive in the cirrhosis that follows
hepatitis than it is in Laennec's cirrhosis, and suggests that it may be of
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value in differentiating the two. Experience in this laboratory appears
to confirm this observation.
The tests are often useful in the differential diagnosis of jaundice.
When positive they suggest an hepatocellular etiology. However, they
may also become positive in obstructive jaundice especially when of
long duration, or complicated by biliary infection. A strongly positive
thymol turbidity test is highly suggestive of some form of hepatitis and
is rarely seen in cirrhosis or obstructive jaundice.
These tests are of very limited value in following the course of
liver disease. Bromsulphalein retention and the serum albumin level
reflect the state of the parenchyma much more accurately. In hepatitis,
the thymol test often becomes positive later than does the cephalin-
flocculation test and persists much longer, often well beyond the stage
where all other signs of liver injury have subsided. Kunkel,20 therefore,
suggests that an increase in thymol turbidity may be an index of re-
generative rather than of inflammatory or degenerative processes.
Slightly elevated values may be diregarded in convalescent hepatitis.
The persistence of high values at this stage, however, is said to indicate
an impending relapse.2'
Recently Neefe 6 has reported that a 24-hour reading of thymol
flocculation may be more sensitive than the turbidity test, and, indeed,
may be the only sign of chronic hepatitis. Others29 have come to essen-
tially the same conclusion. In this laboratory, however, significant
flocculation has invariably been accompanied by an increase in turbidity,
so thatthis modification ofthe original thymol test has been of no value.
Prothrombin level
The plasma prothrombin level may be lowered by liver disease
in one of two ways. There may be a failure of vitamin K absorption
due to lack of bile salts in the intestinal tract, or there may be a defect
in prothrombin synthesis due to hepatocellular damage.
The prothrombin level is of little value in the diagnosis of liver
disease without jaundice, since it is a relatively insensitive test of
hepatic function. The response of a decreased prothrombin level to the
parenteral administration of vitamin K has been advocated as a test
of liver function35 and as a means of differentiating hepatocellular
from obstructive jaundice.12 In this clinic it has proved to be unreliable,
in that a good response has not always excluded parenchymal damage.
The prothrombin level is worth studying, however, for its prognostic
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value. A low level which fails to respond to parenteral vitamin K
in large doses can be taken as a sign of severe liver damage, whether
jaundice is present or not, and it, if persistent, usually indicates a poor
prognosis.
Serum lipids
The liver is an important factor in lipid metabolism, and disturb-
ances in that organ frequently result in alterations of the serum lipid
pattern. The most striking changes are to be seen in the cholesterol
fraction, but the more subtle changes which occur in the other fractions
of the serum lipids, and especially in the phospholipids, may be of
equal importance.23
The level of the total serum cholesterol tends to rise when there is
biliary obstruction, although this is, by no means, a constant finding.
In a general way the degree of hypercholesteremia can be correlated
with the extent and duration of the obstruction. However, hyper-
cholesteremia may also occur with parenchymatous liver disease, es-
pecially in those cases of hepatitis and cirrhosis with clinical features
suggesting intrahepatic obstructive jaundice.
The serum cholesterol level falls when there is extensive parenchy-
mal damage. In the vast majority of patients with parenchymatous liver
disease, however, the total serum cholesterol remains within normal
limits.
The cause for the increase in serum cholesterol in liver disease is
not known. The view that it is due to simple retention33 is open to
serious question. It is based on the assumption that cholesterol is ex-
creted chiefly by the liver, and that suppression of bile, either by
parenchymal damage or by obstruction, results in cholesterol retention
in the blood. Experimental evidence, however, suggests that the in-
testinal mucosa, rather than the liver, is the principal site of cholesterol
excretion.32 Moreover, the observation that hypercholesteremia often
occurs with biliary fistula cannot be explained on the basis of retention,
and suggests another mechanism.
Cholesterol occurs in both free and esterified forms in the serum.
In the absence of liver disease the ratio of the two remains remarkably
constant within narrow limits, irrespective of the total cholesterol
concentration. In all forms of liver disease, however, whether due to
biliary obstruction or to parenchymal damage, there is a tendency for
the esterified fraction to fall.23 It is difficult to account for this relative
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decrease in the esters. It cannot be due solely to a failure of esterification
in the liver, since the absolute values for cholesterol esters are often
abovenormal incases ofliver disease associated with hypercholesteremia.
Compared to some of the other tests of liver function, the serum
cholesterol pattern is relatively insensitive, so that it is not of much
value in the diagnosis of subclinical liver disease, although it may be
confirmatory in some cases. Even in cases with overt liver disease the
total cholesterol and the ratio of the cholesterol esters are often within
normal limits.
The total cholesterol level is occasionally of value in the differential
diagnosis of jaundice. On the whole, high concentrations point to biliary
obstruction, and low values to parenchymal disease. Unfortunately,
the cholesterol level may be quite normal in recent obstruction, and
may be significantly elevated in some forms of parenchymatous liver
disease, especially in that difficult group, already mentioned several
times, in which the clinical* features simulate extrahepatic biliary
obstruction. Low values for total cholesterol, on the other hand, almost
always indicate severe parenchymal damage and may be regarded as
a sign of poor prognosis.
While the ratio of cholesterol esters may be decreased in both
obstructive and parenchymatous jaundice, it may at times, nevertheless
be of value in differential diagnosis. In general, the ester ratio is not
decreased significantly in obstructive jaundice unless hypercholester-
emia is present, so that a low ester ratio usually suggests parenchymal
damage when the total serum cholesterol level is normal. The decrease
in the ester ratio in prolonged obstructive jaundice with hypercho-
lesteremia may also be due to superimposed parenchymatous damage.33
Repeated cholesterol studies are of some value in following the
course of liver disease, but, on the whole, the procedure is technically
so much more difficult than that of many other equally good tests, that
it cannot be recommended for routine use. A decline in the proportion
of esters usually denotes progressive parenchymal damage. In biliary
obstruction with initial hypercholesteremia, a decrease in the total
cholesterol concentration may indicate either a resumption of normal
biliary flow or the development of parenchymal damage, but when it
falls significantly below the normal level it always indicates extensive
parenchymal damage and a poor prognosis.
The concentration of the serum phospholipids tends to parallel
that of the total cholesterol in liver disease. Man and her associates23
stress the importance of an increase in the phospholipid:cholesterol
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ratio, especially in those conditions associated with hypercholesteremia.
The concentration of neutral fat in the serum of patients with liver
disease is usually normal, although itmay be increased in biliary obstruc-
tion and in severe infectious hepatitis.23
The significance of these observations is not yet fully understood,
and while fractionation of all the serum lipids may add to our knowl-
edge offundamental disturbances in the liver, it cannot be recommended
as a routine test of liver function.
Conclusions
1. Liver function tests have their greatest value in the diagnosis
of subclinical liver disease and in following the course of overt liver
disease.
2. They are of far less value than are the history, physical examina-
tion, and other clinical data, in the differential diagnosis of outspoken
disease, and are, at best, confirmatory.
3. The tests are of greatest value to the clinician who understands
their mechanisms and limitations and who keeps clearly in mind his
objectives in doing the tests.
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